ClinicalTrials.gov
ClinicalTrials.gov Menu

Second-line Chemotherapy in Castration Resistant Prostate Cancer (ProstyII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01558219
Recruitment Status : Completed
First Posted : March 20, 2012
Last Update Posted : October 21, 2016
Sponsor:
Collaborators:
Helsinki University Central Hospital
Turku University Hospital
Kuopio University Hospital
Seinajoki Central Hospital
Information provided by (Responsible Party):
Tampere University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2014
  Actual Study Completion Date : December 2014